The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection

Clinical trial NCT04636034 · TERMINATED

Trial details

NCT number: NCT04636034
Sponsor: University Hospital Bispebjerg and Frederiksberg
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Headache Covid19 Sphenopalatine Ganglion Block Persistent Headache Following COVID-19

Start date: 2021-01-12
Primary completion: 2022-06-06
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.